Urologic surgeon and oncologist Armine Smith, M.D., answers questions about the diagnosis and treatment of bladder cancer, and the benefits of choosing Johns Hopkins.
Bladder Cancer: What You Need to Know
- Researchers are finding ways to use genetic sequencing information from a patient’s tumor to choose and design better immunotherapy, targeted therapy, radiation and surgical techniques to improve outcomes of this often-overlooked disease.
- At the Johns Hopkins Greenberg Bladder Cancer Institute, the field’s leading minds take a team approach to patient care in the laboratory and in the Multi-Disciplinary Clinic. Our collaborative team consists of clinician-scientists from urology, urologic surgery, medical oncology, radiation oncology, radiology, pathology and laboratory-based researchers in the JHGBCI Laboratories.
- Meaningful discoveries that translate findings from our laboratories to our clinics are happening here at the Johns Hopkins Greenberg Bladder Cancer Institute.
Comprehensive bladder cancer care is a collaboration between our medical, surgical, pathology and radiation oncology experts, who are as dedicated to providing the best patient experience as they are to improving treatment through research.